Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
Deutsches Zentrum für Neurodegenerative Erkrankungen | Gottingen, Niedersachsen | Germany | about 2 months ago
tools and pipelines, as well as methods for quality control, differential expression, and integrative analyses. Proven expertise in non-coding RNA (ncRNA) biology and epigenetics within the neurosciences
-
of phenotypic and preclinical data from a range of high-throuhput molecular profiling. Of particular interest is the role of the epigenetically modulated changes in gene regulatory programs in therapy resistance
-
BBSRC Yorkshire Bioscience DLA Programme - Decoding the epigenetic language shaping root parasite-host communication School of Biosciences PhD Research Project Competition Funded Students Worldwide
-
investigators (PhD, MD, or MD/PhD) with research expertise in the following areas: Tumor immunology Aging and cancer Transcription factor networks and epigenetics Preference will be given to funded investigators
-
, including gene expression, epigenetic, endocrine, and behavioral datasets. Responsibilities include supporting data processing workflows, assisting with molecular assays, and collaborating closely with other
-
epigenetic regulators, both in physiological and pathological conditions. In the context of a project funded by the French Research Agency (ANR), you will characterise a potential new class of transcriptional
-
Applicants are invited for the above vacancy, based in Epigenetics of Haematopoiesis laboratory at The University of Manchester, tenable from 1 December 2025 until 30 November 2026. Chronic
-
Infrastructure? No Offer Description • Conducting classes for students in the fields of genetics, epigenetics, molecular biology, and laboratory diagnostics, including courses taught in English. • Maintaining and
-
, epigenetics, metabolism, tumor heterogeneity, tumor microenvironment, and the effects of therapy on normal brain tissue. Candidates focused on pediatric or adult brain tumor research, and with a strong interest
-
omics integration; CRISPR and advanced gene editing technologies; epigenetic profiling and modulation; biomarker discovery and validation; personalized therapeutic design; clinical decision support